PAPER Grossberg GT, Olin JT, Somogyi M, Meng X
SEARCH RESULTS
330986 RESULTS
PAPER Uemura K, Farner KC, Nasser-Ghodsi N, Jones P, Berezovska O
Reciprocal relationship between APP positioning relative to the membrane and PS1 conformation.
Mol Neurodegener. 2011;6(1):15. PubMed: 21310068PAPER Liu M, Duggan J, Salt TE, Cordeiro MF
Dendritic changes in visual pathways in glaucoma and other neurodegenerative conditions.
Exp Eye Res. 2011 Apr;92(4):244-50. PubMed: 21310146PAPER Rammes G, Hasenjäger A, Sroka-Saidi K, Deussing JM, Parsons CG
Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
Neuropharmacology. 2011 May;60(6):982-90. PubMed: 21310164PAPER Sankari Z, Adeli H
Probabilistic neural networks for diagnosis of Alzheimer's disease using conventional and wavelet coherence.
J Neurosci Methods. 2011 Apr 15;197(1):165-70. PubMed: 21310177PAPER Post AM, Wultsch T, Popp S, Painsipp E, Wetzstein H, Kittel-Schneider S, Sontag TA, Lesch KP, Reif A
The COGITAT holeboard system as a valuable tool to assess learning, memory and activity in mice.
Behav Brain Res. 2011 Jun 20;220(1):152-8. PubMed: 21310188PAPER Lam V, Takechi R, Pallebage-Gamarallage MM, Galloway S, Mamo JC
Colocalisation of plasma derived apo B lipoproteins with cerebral proteoglycans in a transgenic-amyloid model of Alzheimer's disease.
Neurosci Lett. 2011 Apr 4;492(3):160-4. PubMed: 21310214PAPER Rosenbloom MH, Brown J, Berlowitz DR, Budson AE
Safety and Tolerability of Galantamine SA in Dementia Patients Transitioned from Donepezil.
Consult Pharm. 2011 Feb;26(2):108-10. PubMed: 21310708PAPER Coleman M
Molecular signaling how do axons die?
Adv Genet. 2011;73:185-217. PubMed: 21310297PAPER Chételat G, Villemagne VL, Pike KE, Ellis KA, Bourgeat P, Jones G, O'Keefe GJ, Salvado O, Szoeke C, Martins RN, Ames D, Masters CL, Rowe CC,
Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.
Brain. 2011 Mar;134(Pt 3):798-807. PubMed: 21310725PAPER Tillement L, Lecanu L, Papadopoulos V
Further evidence on mitochondrial targeting of β-amyloid and specificity of β-amyloid-induced mitotoxicity in neurons.
Neurodegener Dis. 2011;8(5):331-44. PubMed: 21311166PAPER Wu PR, Tsai PI, Chen GC, Chou HJ, Huang YP, Chen YH, Lin MY, Kimchi A, Chien CT, Chen RH
DAPK activates MARK1/2 to regulate microtubule assembly, neuronal differentiation, and tau toxicity.
Cell Death Differ. 2011 Sep;18(9):1507-20. PubMed: 21311567PAPER Counts SE, Mufson EJ
PUTATIVE CSF PROTEIN BIOMARKER CANDIDATES FOR AMNESTIC MILD COGNITIVE IMPAIRMENT.
Transl Neurosci. 2010 Mar 1;1(1):2-8. PubMed: 21311725PAPER Pozueta A, Vázquez-Higuera JL, Sánchez-Juan P, Rodríguez-Rodríguez E, Sánchez-Quintana C, Mateo I, Berciano J, Combarros O
Genetic variation in caspase-1 as predictor of accelerated progression from mild cognitive impairment to Alzheimer's disease.
J Neurol. 2011 Aug;258(8):1538-9. PubMed: 21311905PAPER Shaw LM, Vanderstichele H, Knapik-Czajka M, Figurski M, Coart E, Blennow K, Soares H, Simon AJ, Lewczuk P, Dean RA, Siemers E, Potter W, Lee VM, Trojanowski JQ,
Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI.
Acta Neuropathol. 2011 May;121(5):597-609. PubMed: 21311900Current Filters
No filters selected